KIMBERLY CLARK CORP
Company snapshot
A consistent view of the latest supported company value and reported operating results.
Fundamental lens
Four transparent questions from retained financial evidence. Each result stands on its own; Grizzly Bulls does not combine them into a score, ranking, or recommendation.
Trailing-twelve-month net income is positive. As of 2026-03-31.
Trailing-twelve-month operating cash flow less capital expenditures is positive. As of 2026-03-31.
Reported current liabilities exceed reported current assets on the latest comparable retained balance sheet. As of 2026-03-31.
Comparable retained change history is not available through this reader.
How this lens works
Profitability uses only the sign of retained trailing-twelve-month net income. Cash generation uses only the sign of retained trailing-twelve-month free cash flow, defined as operating cash flow less capital expenditures.
Liquidity compares current assets with current liabilities only when both are retained for the same reporting date. It does not infer liquidity from differently dated balance sheets.
Recent operating direction uses the latest supported material financial event when comparable history exists. The existing change methodology requires at least a 10% absolute change or a sign/zero transition and compares quarterly results only with the same fiscal quarter year over year.
Market summary
Completed-session reference prices from IEX for Oct 16, 2026.
Price statistics
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history. Prices are unadjusted. Price returns exclude dividends and are not total returns. Historical statistics appear only when the retained source-session chain is complete and no split-like share-basis discontinuity is detected for that calculation window.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Price history
Recent completed-session closing-price history for this listing. The chart shows raw, unadjusted single-exchange reference observations rather than a consolidated U.S. market close.
Derived reference metrics are omitted for this listing because the required history-quality checks did not clear for the full retained window.
About this market data
IEX historical data reflects IEX activity only and is presented as a source-scoped reference point, not as consolidated U.S. market history.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The raw chart can show a discontinuity around a stock split because it is intentionally unadjusted. The screened metrics use only explicitly registered positive split events and do not assert complete split history.
Listing & sources
Ticker: KMB · Exchange: Nasdaq · Common Stock-$1.25 par value
SEC issuer CIK: 0000055785
Listing source refreshed: 2026-09-13
Financials
SEC-reported financial statement history with filing dates preserved. Annual view retains up to four fiscal years; quarterly view retains up to five fiscal quarters. Missing cells mean a supported fact is unknown and are not treated as zero.
Income statement
| Metric | TTM · 2026-03-31 | FY 2025 · 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $16.56B Filed 2026-04-28 | $16.45B Filed 2026-02-12 | $16.81B Filed 2026-02-12 | $17.15B Filed 2026-02-12 | $20.18B Filed 2025-02-13 |
| Cost of revenue | $10.61B Filed 2026-04-28 | $10.52B Filed 2026-02-12 | $10.52B Filed 2026-02-12 | $10.88B Filed 2026-02-12 | $13.96B Filed 2025-02-13 |
| Gross profit | $5.95B Filed 2026-04-28 | $5.92B Filed 2026-02-12 | $6.29B Filed 2026-02-12 | $6.27B Filed 2026-02-12 | $6.22B Filed 2025-02-13 |
| Operating income | $2.47B Filed 2026-04-28 | $2.35B Filed 2026-02-12 | $2.7B Filed 2026-02-12 | $1.93B Filed 2026-02-12 | $2.68B Filed 2025-02-13 |
| Pretax income | $2.18B Filed 2026-04-28 | $2.05B Filed 2026-02-12 | $2.93B Filed 2025-02-13 | $2.02B Filed 2025-02-13 | $2.34B Filed 2025-02-13 |
| Income tax expense | $632M Filed 2026-04-28 | $599M Filed 2026-02-12 | $442M Filed 2026-02-12 | $343M Filed 2026-02-12 | $495M Filed 2025-02-13 |
| Net income | $2.12B Filed 2026-04-28 | $2.02B Filed 2026-02-12 | $2.55B Filed 2026-02-12 | $1.76B Filed 2026-02-12 | $1.93B Filed 2025-02-13 |
| Diluted EPS | Unavailable | $6.07 Filed 2026-02-12 | $7.55 Filed 2026-02-12 | $5.21 Filed 2026-02-12 | $5.72 Filed 2025-02-13 |
| Diluted shares | Unavailable | 333.2M Filed 2026-02-12 | 337M Filed 2026-02-12 | 338.8M Filed 2026-02-12 | 338.3M Filed 2025-02-13 |
Balance sheet
| Metric | FY 2025 · 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash | $688M Filed 2026-02-12 | $1.01B Filed 2026-02-12 | $1.09B Filed 2025-02-13 | $427M Filed 2024-02-08 |
| Current assets | $5.31B Filed 2026-02-12 | $5.58B Filed 2026-02-12 | $5.7B Filed 2025-02-13 | $5.73B Filed 2024-02-08 |
| Current liabilities | $7.13B Filed 2026-02-12 | $7B Filed 2026-02-12 | $6.93B Filed 2025-02-13 | $7.33B Filed 2024-02-08 |
| Total assets | $17.1B Filed 2026-02-12 | $16.55B Filed 2026-02-12 | $17.34B Filed 2025-02-13 | $17.97B Filed 2024-02-08 |
| Stockholders’ equity | $1.5B Filed 2026-02-12 | $840M Filed 2026-02-12 | $915M Filed 2025-02-13 | $547M Filed 2024-02-08 |
Cash flow
| Metric | TTM · 2026-03-31 | FY 2025 · 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating cash flow | $3.2B Filed 2026-04-28 | $2.78B Filed 2026-02-12 | $3.23B Filed 2026-02-12 | $3.54B Filed 2026-02-12 | $2.73B Filed 2025-02-13 |
| Depreciation & amortization | $780M Filed 2026-04-28 | $805M Filed 2026-02-12 | $781M Filed 2026-02-12 | $753M Filed 2026-02-12 | $754M Filed 2025-02-13 |
| Capital expenditures | $1.36B Filed 2026-04-28 | $1.14B Filed 2026-02-12 | $721M Filed 2026-02-12 | $766M Filed 2026-02-12 | $876M Filed 2025-02-13 |
| Long-term debt issued | Unknown | $0 Filed 2026-02-12 | $0 Filed 2026-02-12 | $363M Filed 2026-02-12 | $0 Filed 2025-02-13 |
| Long-term debt repaid | $700M Filed 2026-04-28 | $550M Filed 2026-02-12 | $554M Filed 2026-02-12 | $475M Filed 2026-02-12 | $312M Filed 2025-02-13 |
| Dividends paid | $1.67B Filed 2026-04-28 | $1.66B Filed 2026-02-12 | $1.63B Filed 2026-02-12 | $1.59B Filed 2024-02-08 | $1.56B Filed 2024-02-08 |
| Stock repurchases | $80M Filed 2026-04-28 | $141M Filed 2026-02-12 | $1B Filed 2026-02-12 | $225M Filed 2026-02-12 | $100M Filed 2025-02-13 |
Calculated from the latest TTM financials
Source: SEC filings. Financial facts retain filing dates and are shown only when the retained source and period alignment support them.
Valuation
Reference valuation uses the latest retained completed-session IEX close and the latest supported SEC-reported share count for a simple single ordinary-share structure.
Open this stock in the Valuation Lab →
Shares outstanding: 332.58M · reported as of 2026-07-28 · filed 2026-08-04
The price is a source-scoped IEX reference close, not a consolidated U.S. market close. P/E and enterprise-value multiples are omitted unless compatible common-equity earnings and complete financing scope are established rather than inferred from adjacent statement fields.
Statistics
Reproducible trailing, quarterly, and annual statistics from retained SEC financials. Growth and return measures appear only when the required reporting periods align; missing denominators are omitted rather than estimated.
Trailing, quarterly, and annual profitability, return, and growth measures derived from retained SEC financials.
Latest annual liquidity measures using same-period reported current assets and current liabilities.
Trailing cash generation plus latest annual dividends and share repurchases where reported.
Historical financial statistics are descriptive accounting measures, not rankings or investment recommendations.
Ownership
No reviewed company-level insider ownership record is available for this listing.